Genetic predisposition to drug-induced hepatotoxicity
- 1 January 1997
- journal article
- review article
- Published by Elsevier in Journal of Hepatology
- Vol. 26, 12-21
- https://doi.org/10.1016/s0168-8278(97)80492-8
Abstract
No abstract availableKeywords
This publication has 57 references indexed in Scilit:
- Characterization of the microsomal epoxide hydrolase gene in patients with anticonvulsant adverse drug reactionsPharmacogenetics, 1994
- Possible association between poor metabolism of mephenytoin and hepatotoxicity caused by Atrium®, a fixed combination preparation containing phenobarbital, febarbamate and difebarbamateJournal of Hepatology, 1994
- Pharmacogenetic Phenotyping and GenotypingClinical Pharmacokinetics, 1994
- The P450 Superfamily: Update on New Sequences, Gene Mapping, Accession Numbers, Early Trivial Names of Enzymes, and NomenclatureDNA and Cell Biology, 1993
- The genetic polymorphism of debrisoquine/sparteine metabolism — Clinical aspectsPharmacology & Therapeutics, 1990
- Genetically determined oxidation polymorphism and drug hepatotoxicityJournal of Hepatology, 1989
- Anticonvulsant hypersensitivity syndrome. In vitro assessment of risk.Journal of Clinical Investigation, 1988
- High Incidence of Poor Sulfoxidation in Patients with Primary Biliary CirrhosisNew England Journal of Medicine, 1988
- Halothane HepatitisNew England Journal of Medicine, 1985
- Predisposition to Phenytoin Hepatotoxicity Assessed in VitroNew England Journal of Medicine, 1981